Human Vaccines & Immunotherapeutics, Volume 16, Issue 6 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Human Vaccines & Immunotherapeutics, Volume 16, Issue 6 (2020)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Volume 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs

Editor’s Corner

Editorial
Letter from the Editor
Page: 1225
Published online: 29 Jun 2020
CitationforLetter from the Editor | Full Text | PDF (95.2 KB) | EPUB
  • 377 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

News, Policy & Profiles

Editorial
Human Vaccines & Immunotherapeutics: news
Pages: 1226-1227
Published online: 29 Jun 2020
CitationforHuman Vaccines & Immunotherapeutics: news | Full Text | References | PDF (160.1 KB) | EPUB
  • 578 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Portrait of an ISV Fellow

Article Commentary
Portrait of an ISV Fellow
Clarisa Beatriz Palatnik de Sousa
Pages: 1228-1231
Published online: 07 May 2020
First Page PreviewforPortrait of an ISV Fellow | Full Text | PDF (381.6 KB) | EPUB
  • 666 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, Maryam Dadar, Yashpal Singh Malik, Karam Pal Singh & Wanpen Chaicumpa
Pages: 1232-1238
Published online: 18 Mar 2020
AbstractforCOVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics | Full Text | References | PDF (980.8 KB) | EPUB
  • 53437 Views
  • 337 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Article Commentary
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
Wen-Hsiang Chen, Peter J. Hotez & Maria Elena Bottazzi
Pages: 1239-1242
Published online: 16 Apr 2020
AbstractforPotential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19 | Full Text | References | PDF (752.7 KB) | EPUB
  • 17737 Views
  • 91 CrossRef citations
  • 0Altmetric
Open Access

Editorial

Editorial
Progress in meningococcal conjugate vaccine development and use
Pages: 1243-1244
Published online: 29 Jun 2020
CitationforProgress in meningococcal conjugate vaccine development and use | Full Text | PDF (152.2 KB) | EPUB
  • 673 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies
Jerome Ateudjieu, Beat Stoll, Anne Cecile Bisseck, Ayok M. Tembei & Blaise Genton
Pages: 1245-1259
Published online: 05 Sep 2019
AbstractforSafety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies | Full Text | References | PDF (1.2 MB) | EPUB
  • 1514 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years
Byung Wook Yoo, Hye Lim Jung, Yoon Seob Byeon, Dong Ki Han, Nak Yeong Jeong, Carlo Curina, Luca Moraschini, Sung Jin Kim, Chiranjiwi Bhusal, Michele Pellegrini & Yan Miao
Pages: 1260-1267
Published online: 25 Oct 2019
AbstractforResults from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1502 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey
Hasan Tezer, Belgin Gülhan, Ayşe Simge Gişi, Selin Nar Ötgün, Saliha Kanık-Yüksek, Aslınur Özkaya-Parlakay, Selçuk Kılıç, Nuriye Ünal Şahin, Asiye Çiğdem Şimşek & Ateş Kara
Pages: 1268-1271
Published online: 12 Dec 2019
AbstractforThe impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey | Full Text | References | PDF (376.9 KB) | EPUB
  • 1106 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
Beatriz Quiambao, Paula Peyrani, Ping Li, Mark W. Cutler, Marie Van Der Wielen, John L. Perez & Chris Webber
Pages: 1272-1279
Published online: 13 May 2020
AbstractforEfficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine | Full Text | References | PDF (1.1 MB) | EPUB
  • 1908 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark Cutler, Ping Li & John L. Perez
Pages: 1280-1291
Published online: 29 Jun 2020
AbstractforTen-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1966 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study
Germán Áñez, James Hedrick, Michael W. Simon, Shane Christensen, Robert Jeanfreau, Eddy Yau, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra
Pages: 1292-1298
Published online: 25 Mar 2020
AbstractforImmunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 4375 Views
  • 21 CrossRef citations
  • 0Altmetric
Open Access
Article
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study
Judith Kirstein, Miriam Pina, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra
Pages: 1299-1305
Published online: 01 Apr 2020
AbstractforImmunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 2432 Views
  • 18 CrossRef citations
  • 0Altmetric
Open Access
Article
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
Timo Vesikari, Ray Borrow, Aino Forsten, Helen Findlow, Mandeep S. Dhingra & Emilia Jordanov
Pages: 1306-1312
Published online: 01 Apr 2020
AbstractforImmunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 3385 Views
  • 18 CrossRef citations
  • 0Altmetric
Open Access

Review

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
Paolo Bonanni, Sara Boccalini, Angela Bechini, Ornella Varone, Giulio Matteo, Federica Sandri & Giovanni Gabutti
Pages: 1313-1321
Published online: 10 Dec 2019
AbstractforCo-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines | Full Text | References | PDF (1.3 MB) | EPUB
  • 1997 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Short Report

Article
Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
Johan L. Van Der Plas, Pauline Verdijk, Emilie M. J. Van Brummelen, Rienk E. Jeeninga, Meta Roestenberg, Jacobus Burggraaf & Ingrid M.C. Kamerling
Pages: 1322-1326
Published online: 20 Dec 2019
AbstractforPrevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season | Full Text | References | PDF (541.1 KB) | EPUB
  • 1797 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Research Paper

Article
Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants
Ann-Muriel Steff, Chanel Cadieux-Dion, Gaël de Lannoy, Maria Key Prato, Xavier Czeszak, Bruno André, Dominique C Ingels, Marc Louckx, Walthère Dewé, Marta Picciolato, Koen Maleux, Laurence Fissette & Ilse Dieussaert
Pages: 1327-1337
Published online: 17 Jan 2020
AbstractforHamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 1907 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Age-stratified analysis of serotype-specific baseline immunity against group B streptococcus
Min Joo Choi, Ji Yun Noh, A-Yeung Jang, Hee Jin Cheong, Woo Joo Kim, Dae Jin Song, Geum Joon Cho, Min Jeong Oh, Yong Zhi, Ho Seong Seo & Joon Young Song
Pages: 1338-1344
Published online: 15 Nov 2019
AbstractforAge-stratified analysis of serotype-specific baseline immunity against group B streptococcus | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 674 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparative genomic analysis of Chinese human leptospirosis vaccine strain and circulating isolate
Ruipeng Zhang, Wenkai Zhou, Qiang Ye, Sichao Song, Yuezhu Wang, Yinghua Xu & Lingbing Zeng
Pages: 1345-1353
Published online: 11 Feb 2020
AbstractforComparative genomic analysis of Chinese human leptospirosis vaccine strain and circulating isolate | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 742 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Narrowing the policy gap: lessons from years 2 and 3 of the British Columbia influenza prevention policy
Antonia M. Di Castri, Donna M. Halperin, Charmaine M. McPherson, Alexandra Nunn, Haley Farrar-Muir, Jeffrey C. Kwong & Bonnie Henry
Pages: 1354-1363
Published online: 10 Jan 2020
AbstractforNarrowing the policy gap: lessons from years 2 and 3 of the British Columbia influenza prevention policy | Full Text | References | PDF (1.1 MB) | EPUB
  • 670 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Maternal influenza vaccination relates to receiving relevant information among pregnant women in Japan
Aiko Shono, Shu-Ling Hoshi & Masahide Kondo
Pages: 1364-1370
Published online: 18 Dec 2019
AbstractforMaternal influenza vaccination relates to receiving relevant information among pregnant women in Japan | Full Text | References | PDF (777.6 KB) | EPUB
  • 627 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparison of immunogenicity between intradermal and intramuscular injections of repeated annual identical influenza virus strains post-pandemic (2011-2012) in COPD patients
Benjamas Chuaychoo, Uraiwan Kositanont, Parichat Niyomthong, Nuttapol Rittayamai, Sorachai Srisuma, Kanokwan Rattanasaengloet, Walaiporn Wongsrisakunkaew, Julalux Thongam & Thaweesak Songserm
Pages: 1371-1379
Published online: 26 Nov 2019
AbstractforComparison of immunogenicity between intradermal and intramuscular injections of repeated annual identical influenza virus strains post-pandemic (2011-2012) in COPD patients | Full Text | References | PDF (860 KB) | EPUB
  • 848 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Article
Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial
Joyce Ojeda, José Luis Arredondo, Perla Salcedo, Mercedes Paredes-Paredes, Martin Dupuy, Celine Petit, Anne Laure Chabanon, Enrique Rivas, Sanjay Gurunathan, Iris De Bruijn & Stephanie Pepin
Pages: 1380-1384
Published online: 20 Dec 2019
AbstractforImmunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial | Full Text | References | PDF (829.7 KB) | EPUB | Supplemental
  • 1574 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Research Paper

Article
Intersectoral cooperation to increase HPV vaccine coverage: an innovative collaboration between Managed Care Organizations and state-level stakeholders
Natoshia Askelson, Grace Ryan, Laura Seegmiller, Alexander Preiss & Sara Comstock
Pages: 1385-1391
Published online: 06 Dec 2019
AbstractforIntersectoral cooperation to increase HPV vaccine coverage: an innovative collaboration between Managed Care Organizations and state-level stakeholders | Full Text | References | PDF (774.4 KB) | EPUB
  • 736 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12–15 years: end-of-study results from a community-randomized study up to 6.5 years
Dan Bi, Dan Apter, Tiina Eriksson, Mari Hokkanen, Julia Zima, Silvia Damaso, Maaria Soila, Gary Dubin, Matti Lehtinen & Frank Struyf
Pages: 1392-1403
Published online: 12 Dec 2019
AbstractforSafety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12–15 years: end-of-study results from a community-randomized study up to 6.5 years | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 3551 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population
Rebecca K. Hollenberg, Diane R. Krieger, Robert Samuels, Kim Kraynyak, Albert Sylvester, Matthew Morrow, Jean Boyer, Michael Dallas & Prakash K. Bhuyan
Pages: 1404-1412
Published online: 20 Dec 2019
AbstractforSafety and immunogenicity of VGX-3100 formulations in a healthy young adult population | Full Text | References | PDF (1.1 MB) | EPUB
  • 2792 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Analysis of the CD8+ IL-10+ T cell response elicited by vaccination with the oncogenic tumor-self protein D52
C. Riccay Elizondo, Jennifer D. Bright, Jennifer A. Byrne & Robert K. Bright
Pages: 1413-1423
Published online: 26 Nov 2019
AbstractforAnalysis of the CD8+ IL-10+ T cell response elicited by vaccination with the oncogenic tumor-self protein D52 | Full Text | References | PDF (2.1 MB) | EPUB
  • 624 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Review

Emerging CAR T cell therapies: clinical landscape and patent technological routes
Virgínia Picanco-Castro, Cristiano Gonçalves Pereira, Kamilla Swiech, Kelen Cristina Ribeiro Malmegrim, Dimas Tadeu Covas & Geciane Silveira Porto
Pages: 1424-1433
Published online: 06 Dec 2019
AbstractforEmerging CAR T cell therapies: clinical landscape and patent technological routes | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 2610 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10
Kelei Li, Fangyu Dong, Bopei Cui, Lisha Cui, Pei Liu, Chao Ma, Haifa Zheng, Xing Wu & Zhenglun Liang
Pages: 1434-1440
Published online: 18 Dec 2019
AbstractforDevelopment of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10 | Full Text | References | PDF (983 KB) | EPUB
  • 814 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Case Report

Case Report
Satisfactory immune response following anaphylaxis to PCECV facilitated by the use of steroids and antihistamines
Abishek Tumma, Kari Jarvinen, Brad McCall, Richard Wong & Marjoree Sehu
Pages: 1441-1443
Published online: 06 Dec 2019
AbstractforSatisfactory immune response following anaphylaxis to PCECV facilitated by the use of steroids and antihistamines | Full Text | References | PDF (296.6 KB) | EPUB
  • 910 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Article Commentary
Polio vaccination campaign in Pakistan: a step towards eradication or still a challenge in hand?
Tauseef Ahmad, Muhammad Khan, Taha Hussein Musa & Jin Hui
Pages: 1444-1445
Published online: 25 Mar 2020
AbstractforPolio vaccination campaign in Pakistan: a step towards eradication or still a challenge in hand? | Full Text | References | PDF (358.5 KB) | EPUB
  • 2786 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain
I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez & F. Martinón-Torres
Pages: 1446-1453
Published online: 18 Dec 2019
AbstractforRoutine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1137 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Review

Armed conflict, a neglected determinant of childhood vaccination: some children are left behind
Ngo Valery Ngo, Ngambouk Vitalis Pemunta, Nyenkuna Elisabeth Muluh, Miranda Adedze, Nduma Basil & Simon Agwale
Pages: 1454-1463
Published online: 06 Dec 2019
AbstractforArmed conflict, a neglected determinant of childhood vaccination: some children are left behind | Full Text | References | PDF (1.8 MB) | EPUB
  • 4643 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access

Research Paper

Article
Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial
Innocent Valéa, Samuel Adjei, Effua Usuf, Ousmane Traore, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Athanase Mwinessobaonfou Some, Patrick Buabeng, Johan Vekemans, Amos Kotey, Pascale Vandoolaeghe, Mark Cullinane, Magali Traskine, Florence Ouedraogo, David Sambian, Marc Lievens, Marc Christian Tahita, Erik Jongert, Palpouguini Lompo, Ali Idriss, Dorota Borys, Sayouba Ouedraogo, Frank Prempeh, Lode Schuerman, Hermann Sorgho & Tsiri Agbenyega
Pages: 1464-1470
Published online: 17 Jan 2020
AbstractforLong-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2380 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Correction

Correction
Correction
Page: 1471
Published online: 22 Apr 2020
CitationforCorrection | Full Text | PDF (88.6 KB) | EPUB
  • 399 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Exploring the challenges and interventions of urban-poor vaccination in the Philippines
Dalmacito A. Cordero Jr.
Letter to the Editor | Published online: 9 Jul 2024
Open Access
4CMenB journey to the 10-year anniversary and beyond
Véronique Abitbol et al.
Review Article | Published online: 8 Jul 2024
Open Access
Financial hindrances to introducing higher-valent pediatric combination vaccines
Floriano Amimo
Letter to the Editor | Published online: 8 Jul 2024
Open Access
Reply to “Financial hindrances to introducing higher-valent pediatric combination vaccines”
Aodi Huang et al.
Letter to the Editor | Published online: 8 Jul 2024
Open Access